Skip to Main Content

Author Details

Zhaleh Safikhani
Princess Margaret Cancer Center, University Health Network
2013
19
11
PMIDPaper TitleJournal TitlePublished Year
35585485Evaluation of statistical approaches for association testing in noisy drug screening data.BMC Bioinformatics2022
35585485Evaluation of statistical approaches for association testing in noisy drug screening data.BMC Bioinformatics2022
32566759Machine learning approaches to drug response prediction: challenges and recent progress.NPJ Precis Oncol2020
32937114Assessment of Genetic Drift in Large Pharmacogenomic Studies.Cell Syst2020
32566759Machine learning approaches to drug response prediction: challenges and recent progress.NPJ Precis Oncol2020
32937114Assessment of Genetic Drift in Large Pharmacogenomic Studies.Cell Syst2020
31481707Creating reproducible pharmacogenomic analysis pipelines.Sci Data2019
31481707Creating reproducible pharmacogenomic analysis pipelines.Sci Data2019
29016819Tissue specificity of in vitro drug sensitivity.J Am Med Inform Assoc2018
29016819Tissue specificity of in vitro drug sensitivity.J Am Med Inform Assoc2018
30053271PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies.Nucleic Acids Res2018
30084834Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.Clin Cancer Res2018
30410118The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism.Sci Rep2018
29378962Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.Proc Natl Acad Sci U S A2018
29317617Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro.Nat Commun2018
30053271PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies.Nucleic Acids Res2018
30084834Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.Clin Cancer Res2018
30410118The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism.Sci Rep2018
29378962Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.Proc Natl Acad Sci U S A2018
29317617Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro.Nat Commun2018
29066719Gene isoforms as expression-based biomarkers predictive of drug response in vitro.Nat Commun2017
29066719Gene isoforms as expression-based biomarkers predictive of drug response in vitro.Nat Commun2017
28314784Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy.Cancer Res2017
28314784Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy.Cancer Res2017
27408686Assessment of pharmacogenomic agreement.F1000Res2016
27408686Assessment of pharmacogenomic agreement.F1000Res2016
26656004PharmacoGx: an R package for analysis of large pharmacogenomic datasets.Bioinformatics2016
26463000Public data and open source tools for multi-assay genomic investigation of disease.Brief Bioinform2016
27905430Safikhani et al. reply.Nature2016
27905423Safikhani et al. reply.Nature2016
27905416Safikhani et al. reply.Nature2016
26463000Public data and open source tools for multi-assay genomic investigation of disease.Brief Bioinform2016
26656004PharmacoGx: an R package for analysis of large pharmacogenomic datasets.Bioinformatics2016
27905430Safikhani et al. reply.Nature2016
27905423Safikhani et al. reply.Nature2016
27905416Safikhani et al. reply.Nature2016
24161398SSP: an interval integer linear programming for de novo transcriptome assembly and isoform discovery of RNA-seq reads.Genomics2013
24161398SSP: an interval integer linear programming for de novo transcriptome assembly and isoform discovery of RNA-seq reads.Genomics2013
  • 1 - 38 of 38

Recommended Authors

Lang Li
College of Medicine, The Ohio State University
Career Start Year 2018
Number of shared co-authors 0
Rebecca Kusko
Immuneering Corporation
Career Start Year 2012
Number of shared co-authors 5
Kelly Regan
The Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 0
Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 1
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 2
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 1
Justin Guinney
University of Washington
Career Start Year 2006
Number of shared co-authors 3
Kouros Owzar
Duke University
Career Start Year 2005
Number of shared co-authors 0
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 1
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 0
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 5
Lang Li
Harbin Medical University
Career Start Year 2002
Number of shared co-authors 0
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Keyue Ding
Queen's University
Career Start Year 2002
Number of shared co-authors 1
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Cristina Rodr??guez-Antona
Spanish National Cancer Research Center (CNIO)
Career Start Year 2000
Number of shared co-authors 0
Sunkyu Kim
Korea University
Career Start Year 2000
Number of shared co-authors 1
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 2
Liewei Wang
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 1
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 0
Andrey Loboda
Merck & Co., Inc.
Career Start Year 1998
Number of shared co-authors 1
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 4
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Atul J Butte
Bakar Computational Health Sciences Institute, University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Weida Tong
National Center for Toxicological Research
Career Start Year 1992
Number of shared co-authors 4
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 1
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 14

Collaborators

Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 18
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Co-authored papers 12
Anna Goldenberg
SickKids Research Institute
Co-authored papers 7
Hugo J W L Aerts
Harvard Medical School
Co-authored papers 5
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 4
David W Cescon
Princess Margaret Cancer Centre
Co-authored papers 4
Deena M A Gendoo
Institute of Cancer and Genomic Sciences, University of Birmingham
Co-authored papers 4
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
John Quackenbush
Harvard T. H. Chan School of Public Health
Co-authored papers 4
Wail Ba-Alawi
Princess Margaret Cancer Centre, University Health Network, University Ave.
Co-authored papers 3
Mathieu Lupien
Princess Margaret Cancer Research Centre
Co-authored papers 3
Lavanya Kannan
NYU School of Medicine
Co-authored papers 2
Levi Waldron
City University of New York School of Public Health
Co-authored papers 2
Seyed Ali Madani Tonekaboni
Princess Margaret Cancer Research Centre
Co-authored papers 1
Ruth Isserlin
University of Toronto
Co-authored papers 1
Marcel Ramos
Graduate School of Public Health and Health Policy, City University of New York
Co-authored papers 1
Arvind Singh Mer
University of Ottawa
Co-authored papers 1
Martin Morgan
Roswell Park Comprehensive Cancer Center
Co-authored papers 1
Ming Shi
Co-authored papers 1
Robert Castelo
Universitat Pompeu Fabra (UPF)
Co-authored papers 1
Marc Hafner
Harvard Medical School
Co-authored papers 1
Vincent J Carey
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Co-authored papers 1
Gregory M Chen
University of Pennsylvania
Co-authored papers 1
Tero Aittokallio
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Co-authored papers 1
David Gomez-Cabrero
King Abdullah University of Science and Technology
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Giovanni Parmigiani
Dana Farber Cancer Institute.
Co-authored papers 1
Michael J Birrer
Co-authored papers 1
Release 1.2